Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

Lyell is entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. While enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. Cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.lyellbiotech.com
Founded2018
Disease Focus
Development Stage
STOCK CODENon Listed
Address
883 Robb Road, CA, 94306
Palo Alto
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/lyell” connections=”true” suffix=””]